- Country: Poland
- Summary: Delivery of Medicinal Products from the Group: Drugs Available as Part of a Drug Program; Drugs Used as Part of Chemotherapy in the Entire Range of Registered Indications and Destinations and in the Indication Specify ...
- PLT Ref No: 121775073
- Deadline: 28 Jul 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 418645-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Delivery of medicinal products from the group: Drugs available as part of a drug program; Drugs used as part of chemotherapy in the entire range of registered indications and destinations and in the indication specify ...
Drugs, used as part of chemotherapy, the entire scope of registered indications and destinations and in the indication of a specific clinical condition; anti -cancer and immunomodulatory drugs as well as non -specific immunoglobulins (according to ATC classification) divided into 105 tasks.
Delivery of medicinal products from the group: Drugs available as part of a drug program; Drugs used as part of chemotherapy
in the entire scope of registered indications and destinations and in the indication with a specific clinical condition; anti -cancer and immunomodulatory drugs as well as non -specific immunoglobulins (according to ATC classification) with division out of 105 tasks. ZP/PN/54/25/LSOFA/JG
1immunoglobulinum humanum - preparation with content: IGG at least 98%; Iga max 280yg/ml*
craze. 1 g/5 ml
2immunoglobulinum humanum for subcutaneous administration; A preparation with an IGG content of at least 95%; Iga has 50ug/ml; Vioola.≤0.2 g/ml
1g/5 ml
3infliximabum
craze. 100 mg
4inotuzumabum ozogamini
viole
5ipilimumab
craze. 50 mg
6irinotecanum or Derivative
250mg
coat 250 mg
11Lenalidomidum
caps.tward 25 mg
12Lomustinum
40 mg capsules
13Lorlatinibum
vial 1200 ml
100 mg
16methotrexatum
craze. 5000 mg/50 ml
17M... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDelivery of Medicinal Products from the Group: Drugs Available as Part of a Drug Program; Drugs Used as Part of Chemotherapy in the Entire Range of Registered Indications and Destinations and in the Indication Specify ... - Poland Tender
The LOWER SILESIAN CENTER OF ONCOLOGY, PULMONOLOGY AND HEMATOLOGY, a Government sector organization in Poland, has announced a new tender for Delivery of Medicinal Products from the Group: Drugs Available as Part of a Drug Program; Drugs Used as Part of Chemotherapy in the Entire Range of Registered Indications and Destinations and in the Indication Specify .... This tender is published on PolandTenders under PLT Ref No: 121775073 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-07-28.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
